5-HT2c |
serotonin receptor type 2C |
α2MG |
α2 macroglobulin |
Aβ |
amyloid-β |
ACE |
angiotensin convertase |
Ach |
acetylcholine |
AchE |
acetylcholinesterase |
ACTH |
adrenocorticotropic hormone |
ADAM |
disintegrin and metalloprotease domain |
ADAMTS4 |
ADAM with a thrombospondin type 1 motif, member 4 |
ADP |
anterodorsal preoptic nucleus |
Al |
aluminum |
ALS |
amyotrophic lateral sclerosis |
AMPA |
α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid |
AMPK |
5′ adenosine mono-phosphate-activated protein kinase |
apoE |
apolipoprotein E |
APJ |
putative receptor protein related to ATl |
APP |
amyloid precursor protein |
AQP |
aquaporin |
ARAS |
ascending reticular activation system |
ARC |
arcuate nucleus |
AVP |
arginine vasopressin |
AVPV |
anteroventral periventricular nucleus |
BACE |
β-site APP-cleaving enzyme |
BBB |
blood–brain barrier |
BChE |
butyrylcholinesterase |
BDNF |
brain-derived neurotrophic factor |
Ca |
calcium |
cAMP |
cyclic adenosine monophosphate |
CAMK II |
calcium calmodulin-dependent protein kinase II |
CCK |
cholecystokinin |
CDK |
cyclin-dependent kinase |
CGRP |
calcitonin gene-related peptide |
CHK1 |
cell cycle checkpoint protein kinase 1 |
CIP2A |
cancerous inhibitor of protein phosphatase 2 |
CJD |
Creutzfeldt–Jakob disease |
CNS |
central nervous system |
CRF |
corticotrope-releasing factor |
CRFBP |
CRF-binding protein |
CRFR |
CRF receptor |
CTE |
chronic traumatic encephalopathy |
Cu |
copper |
CSF |
cerebrospinal fluid |
DAG |
diacylglycerol |
DRD2 |
dopamine receptor type 2 |
ECE |
endothelin-converting enzyme |
eNOS |
endothelial nitric oxide synthase |
EOAD |
early-onset Alzheimer’s disease |
FAD |
familial Alzheimer’s disease |
FDA |
Food and Drug Administration |
FKBP51 |
tacrolimus (FK506)-binding protein 51 |
FMLP |
N-formyl-Methionine-Leucin-Phenylalanine |
FSH |
follicle-stimulating hormone |
FTD |
frontotemporal lobar degeneration |
GAS |
general adaptation syndrome |
GBM |
glioblastoma |
GH |
growth hormone |
GHS-R |
growth hormone secretagogue receptor |
ghrelin-R |
ghrelin receptor |
GHRH |
GH-releasing hormone |
GHRH-R |
GHRH receptor |
GnRH |
gonadotropin-releasing hormone |
GnRH-R |
gonadotropin-releasing hormone receptor |
GIP |
glucose-dependent insulinotropic polypeptide |
GLP-1 |
glucagon-like peptide 1 |
Glu |
glutamate |
GLUT |
glucose transporter |
GOAT |
ghrelin O-acyltransferase |
GnIH |
gonadotropin-inhibitory hormone |
GOF |
gain of function |
GPCRs |
G protein-coupled receptors |
GSK-3β |
glycogen synthase kinase 3β |
HPA |
hypothalamic–pituitary–adrenal cortex |
HPG |
hypothalamic–pituitary–gonadal |
IDE |
insulin-degrading enzyme |
IGF |
insulin-like growth factor |
IP3 |
Inositol triphosphate |
Jak |
Janus kinase |
JNK |
c-Jun N-terminal kinases |
KNDy |
kisspeptin, dynorphin-A, and neurokinin-B cosecretory |
KISSR1 |
kisspeptin receptor |
KOR |
kappa opioid receptor |
KP |
kisspeptin |
LC |
locus coeruleus |
LDT |
lateral dorsal tegmental |
LH |
luteinizing hormone |
LHRH |
luteinizing hormone-releasing hormone |
LOAD |
late-onset Alzheimer’s disease |
LOF |
loss of function |
LRP |
lipoprotein receptor-related protein |
MAPK |
mitogen-activated protein kinase |
MC3R |
melanocortin-3 receptor |
MCH |
melanin-concentrating hormone |
Mg |
magnesium |
MMP |
matrix metalloprotease |
Mn |
manganese |
MS |
multiple sclerosis |
MT |
mesopontine tegmentum |
mtDNA |
mitochondrial DNA |
mTOR |
mammalian target of rapamycin |
MWM |
Morris water maze |
NCX |
Na+/Ca2+ exchanger |
NEP |
neprilysin |
NGF |
nerve growth factor |
NFκB |
nuclear factor κ B |
NLRP3 |
Nod-like receptor protein 3 |
NMDA |
N-methyl-D-aspartate |
NM |
neuromedin |
NMN |
neuromedin N |
NMS |
neuromedin S |
NMU |
neuromedin U |
NO |
nitric oxide |
NP |
natriuretic peptide |
NPAF |
neuropeptide AF |
NPFF |
neuropeptide FF |
NPFFR1 |
neuropeptide FF receptor 1 |
NPFFR2 |
neuropeptide FF receptor 2 |
NPSF |
neuropeptide SF |
NPY |
neuropeptide Y |
NR |
nucleus raphe |
NRC3C1 |
nuclear receptor subfamily 3, group C, and member 1 |
NSCCs |
non-selective cation channels |
NT |
neurotensin |
OCD |
obsessive compulsive disorder |
OXR |
orexin receptor |
OX1R |
orexin-1 receptor |
OX2R |
orexin-2 receptor |
PACAP |
pituitary adenylate cyclase-activating peptide |
PeN |
periventricular nucleus |
PG |
periaqueductal grey |
PKC |
protein kinase C |
PLC |
phospholipase-C |
POA |
preoptic area |
POCD |
postoperative cognitive dysfunction |
POMC |
pro-opiomelanocortin |
PPT |
pedunculopontine tegmental nucleus |
PrD |
prion disease |
PrP |
prion protein |
PrPc |
cellular prion protein |
PrPp |
scrapie prion protein |
PrRP |
prolactin-releasing peptide |
PrRPR |
prolactin-releasing peptide receptor |
PSEN |
presenilin |
PSP |
progressive supranuclear palsy |
PTP |
phosphotyrosine phosphatase |
PVN |
paraventricular nuclei |
QRFP |
pyroglutamylated RFamide |
QRFP-R |
pyroglutamylated RFamide peptide receptor |
RAAS |
renin angiotensin aldosterone system |
RAGE |
receptor for advanced glycation end products |
RFamide |
arginine–phenylalanine–amide |
ROS |
reactive oxygen species |
SA |
sympathoadrenal |
SAD |
sporadic Alzheimer’s disease |
SAPP-α |
soluble APP-α |
SCN |
suprachiasmatic nucleus |
SIRS |
severe inflammatory response syndrome |
SOD |
superoxide dismutase |
SON |
supraoptic nucleus |
SV |
splice variant |
TBIs |
traumatic brain injuries |
TNFα |
tumor necrosis-α |
TRH |
thyrotropin-releasing hormone |
TrK |
tyrosine kinase |
UCN |
urocortin |
Unc |
uncoordinated |
ULK1 |
Unc-51-like autophagy-activating kinase 1 |
UPS |
ubiquitin–proteasome system |
URP |
urotensin-related peptide |
UTN |
urotensin |
V1BR |
vasopressin 1B receptor |
V1R |
vasopressin 1 receptor |
vCJD |
variant Creutzfeldt–Jakob disease |
Zn |
zinc |